Prabhudas Lilladher's research report on Clean Science and Technology
Clean Science and Technology (CLEAN) reported Q2FY25 revenue of Rs2.38bn, up 31.5% YoY and 6.3% QoQ. This YoY increase was driven by higher volumes, especially within the Performance Chemicals segment. However, due to rising raw material costs, the company experienced margin compression, despite stable product realization, which is expected to remain steady in the next few quarters. HALS sales reached 135t per month, with the plant operating at under 20% capacity utilization. Recently launched HALS products are anticipated to support revenue growth sequentially. On the capex front, the company has announced investment in a water-treatment chemical project, expected to commence operations by Dec’25, with an estimated peak revenue potential of ~Rs3bn. Additionally, the pharma intermediate plant is on schedule and is slated for commercialization within this quarter. Going ahead, we anticipate these new capex projects to drive revenue growth.
Outlook
However, margins may face downward pressure, as some of the new products have lower margins compared to the company’s legacy offerings. Currently, the company trades at 42x FY27 EPS. We maintain ‘Hold’ rating with a target price of Rs1,526, valuing the company at 46x FY26/FY27 EPS.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.